Granstein R D, Murphy G F, Margolis R J, Byrne M H, Amento E P
J Clin Invest. 1987 Apr;79(4):1254-8. doi: 10.1172/JCI112945.
Subcutaneous implantation of osmotic pumps into CAF1 mice resulted in the formation of thick fibrous capsules around the pumps. When pumps were loaded with recombinant murine gamma-interferon (rMuIFN-gamma) to deliver 2 X 10(3) U/h for 14 d, there was a marked decrease in thickness and collagen content of the capsules from rMuIFN-gamma-treated animals compared with capsules from animals receiving diluent alone. The collagen content of the capsules was estimated by hydroxyproline analysis of the tissue and by quantitative electron microscopy of collagen bundles. Heat-inactivated rMuIFN-gamma failed to reduce the fibrotic response in this assay. These results provide compelling evidence that gamma-interferon can down-regulate collagen synthesis in vivo and suggest the possibility that this lymphokine may be useful in the treatment of disease states characterized by excessive fibrosis.
将渗透泵皮下植入CAF1小鼠体内,导致泵周围形成厚厚的纤维囊。当泵中装入重组鼠γ干扰素(rMuIFN-γ)以14天内每小时输送2×10³单位时,与仅接受稀释剂的动物的囊相比,接受rMuIFN-γ治疗的动物的囊厚度和胶原蛋白含量显著降低。通过对组织进行羟脯氨酸分析和对胶原束进行定量电子显微镜观察来估计囊的胶原蛋白含量。热灭活的rMuIFN-γ在该试验中未能降低纤维化反应。这些结果提供了令人信服的证据,表明γ干扰素可以在体内下调胶原蛋白合成,并提示这种淋巴因子可能对治疗以过度纤维化为特征的疾病状态有用。